Bp PLC Exact Sciences Corp Transaction History

Bp PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$90.24 - $124.05 $365,832 - $502,898	-4,054 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$93.66 - $139.27 $124,755 - $185,507	-1,332 Reduced 24.73%	4,054 $503,000
Q1 2021 May 13, 2021	SELL	$116.57 - $155.01 $124,380 - $165,395	-1,067 Reduced 16.53%	5,386 $710,000
Q4 2020 Feb 08, 2021	SELL	$99.61 - $142.12 $672,068 - $958,883	-6,747 Reduced 51.11%	6,453 $855,000
Q3 2020 Oct 30, 2020	SELL	$72.92 - $102.01 $80,212 - $112,211	-1,100 Reduced 7.69%	13,200 $1.35 Million
Q2 2020 Aug 05, 2020	BUY	$55.75 - $92.75 $797,225 - $1.33 Million	14,300 New	14,300 $1.24 Million

670

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.39B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

Stay updated on Bp PLC with notifications on news.